JP Morgan Chase’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
JP Morgan Chase's RXST Position: Q1 2026 in Review
JP Morgan Chase increased its RxSight (RXST) stake by 93% in Q1 2026, buying an estimated $1.96M and bringing the position to 488,641 shares worth $2.98M. The position accounts for ﹤0.01% of the portfolio, ranked #3785.
JP Morgan Chase first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $24.1M in Q4 2023. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- JP Morgan Chase held 488,641 shares of RxSight worth $2.98M as of Q1 2026.
- JP Morgan Chase bought 236,043 RxSight shares in Q1 2026, an estimated $1.96M.
- RxSight made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3785 holding.
- JP Morgan Chase first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
- JP Morgan Chase's RxSight position peaked at $24.1M in Q4 2023.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.